AI assistant
HEALTHEQUITY, INC. — Director's Dealing 2017
Sep 22, 2017
30722_dirs_2017-09-22_82bea0af-72a7-4c21-af95-0297ca71c1e9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEALTHEQUITY INC (HQY)
CIK: 0001428336
Period of Report: 2017-09-20
Reporting Person: MOTT DARCY G (Executive VP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-20 | Common Stock | M | 12500 | $1.25 | Acquired | 87500 | Direct |
| 2017-09-20 | Common Stock | S | 9500 | $46.7898 | Disposed | 78000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-20 | Stock Option (right to buy) | $1.25 | M | 12500 | Disposed | 2021-08-08 | Common Stock (12500) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $41.28 | 2027-03-27 | Common Stock (19897) | 19897 | Direct |
| Stock Option (right to buy) | $14 | 2024-07-30 | Common Stock (30000) | 30000 | Direct |
| Stock Option (right to buy) | $25.39 | 2025-03-26 | Common Stock (25000) | 25000 | Direct |
Footnotes
F1: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.51 to $47.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
F3: The option is immediately exercisable.
F4: The option becomes exercisable in three annual installments of 4,974 shares on March 27, 2018, 2019, and 2020 and in one installment of 4,975 shares on March 27, 2021.
F5: The option became exercisable as to 6,250 shares on each of March 26, 2016 and 2017. The remaining shares become exercisable in two equal annual installments of 6,250 shares on March 26, 2018 and 2019.